Highlights AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 16:35:16 18/06/2025 BST			5-day change	1st Jan Change
10,548.00 ^GBX	-1.07%		-2.98%	+0.76%

06-02	ASTRAZENECA : Buy rating from JP Morgan	ZD
06-02	UK's FTSE 100 closes around flat as staples, healthcare losses eclipse energy gains	RE

Highlights

Kennedy's new US vaccine panel to discuss measles shot for children	09:41pm	RE
Kennedy's new US vaccine panel to discuss measles shot for children	06:40pm	RE
CDC's vaccine advisory committee to vote on RSV, flu shots	04:16pm	RE
HBM Repurchases HK$9 Million in Shares, Highlights Milestone Deals	03:51am	MT
Top Midday Stories: Shares Decline Amid Unease Over Israel-Iran Conflict; Retail Sales Fall More Than Expected in May	06-17	MT
Trump Administration to Consider Pharma Advertising Crackdown	06-17	MT
Trump Administration to Consider Pharma Advertising Crackdown, Bloomberg reports	06-17	MT
Huahai Pharmaceutical Gets Registration Certificate for Quetiapine Fumarate Tablets	06-16	MT
AstraZeneca, CSPC Pharmaceuticals Enter Research Agreement	06-13	MT
AstraZeneca: R&D agreement with CSPC Pharmaceuticals Group	06-13	CF
AstraZeneca Enters Strategic Collaboration with CSPC Pharmaceuticals Group Limited	06-13	CI
AstraZeneca boosts China ties with up to USD5.3 billion partnership	06-13	AN
AstraZeneca, CSPC Ink Strategic Research Collaboration for AI-Driven Drug Discovery	06-13	MT
US Senators Introduce Bill to Ban Direct-to-Consumer Drug Ads	06-12	MT
US Health Secretary to Revamp Vaccine Advisory Committee	06-10	MT
US FDA approves Merck's RSV antibody for infants	06-09	RE
IonQ Speeds Quantum-Accelerated Drug Development Application with AstraZeneca, AWS, and NVIDIA	06-09	CI
AstraZeneca plc Announces Fixed-Term Calquence Approval in EU for 1L CLL	06-06	CI
AstraZeneca Scores EU Approval for New Fixed-Duration Leukemia Treatment	06-06	MT
AstraZeneca plc Announces Fixed-Term Calquence -Based Regimens Approved in EU for Patients with Chronic Lymphocytic Leukaemia in the 1st-Line Setting AMPLIFY Phase III	06-06	CI
AstraZeneca Wins EU Nod for Calquence-based Leukemia Treatment Regimens	06-06	MT
AstraZeneca: Enhertu promising against breast cancer	06-05	CF
Perrigo Company plc Announces Executive Changes	06-04	CI
M42 Partners with AstraZeneca, Sophia Genetics for Liquid Biopsy Testing in UAE	06-03	MT
Global markets live: Tesla, Sanofi, Apple, JPMorgan, Microsoft…	06-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ASTRAZENECA : Sustained operational strength leads to an upgrade

May 20, 2025 at 03:42 pm

AstraZeneca Gets Profit Boost From Diabetes, Cancer Drugs

April 29, 2025 at 10:46 am